EXPONENT INC
For the period ended Apr 4, 2025. Filed May 9, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 4, 2025 · Filed May 9, 2025
EXPO$86.00+0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three Months Ended | ||
|---|---|---|
| (In thousands) | April 4, 2025 | March 29, 2024 |
| Cash flows from operating activities: | ||
| Net income | $26,650 | $30,142 |
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Depreciation and amortization of property, equipment and leasehold improvements | 2,492 | 2,324 |
| Provision for contract losses and doubtful accounts | 256 | 1,279 |
| Stock-based compensation | 8,179 | 7,340 |
| Deferred income tax provision | (3,226) | 1,600 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (5,637) | 3,196 |
| Prepaid expenses and other current assets | (3,331) | (2,193) |
| Change in operating leases | 454 | (614) |
| Accounts payable and accrued liabilities | 11,595 | 2,577 |
| Accrued payroll and employee benefits | (27,571) | (29,616) |
| Deferred revenues | (2,587) | (5,603) |
| Net cash provided by operating activities | 7,274 | 10,432 |
| Cash flows from investing activities: | ||
| Capital expenditures | (1,754) | (1,482) |
| Net cash used in investing activities | (1,754) | (1,482) |
| Cash flows from financing activities: | ||
| Payroll taxes for restricted stock units | (4,166) | (6,796) |
| Repurchase of common stock | - | (5,466) |
| Exercise of stock-based payment awards | 484 | 618 |
| Dividends and dividend equivalents rights | (16,367) | (15,583) |
| Net cash used in financing activities | (20,049) | (27,227) |
| Effect of foreign currency exchange rates on cash and cash equivalents | 741 | (208) |
| Net decrease in cash and cash equivalents | (13,788) | (18,485) |
| Cash and cash equivalents at beginning of period | 258,901 | 187,150 |
| Cash and cash equivalents at end of period | $245,113 | $168,665 |
-7 -
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.